ACADIA Pharmaceuticals Inc (ACAD) Company Long-Term Loans and Borrowings

Public company logo of ACADIA Pharma (ACAD)

Geopolitical tensions are hindering global drug trials and disrupting raw material supplies for ACADIA Pharmaceuticals (ACAD). The dynamics of the business's long-term debt capital illustrate the lending strategy, where the 0.06 mark indicates the current status. The rising value of Nuplazid and Daybue, combined with M&A potential, create growth drivers, while stable demand for Parkinson's therapy guarantees cash flow despite the risk of patent expirations.

ACAD ACADIA Pharmaceuticals: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

ACADIA Pharmaceuticals Inc (ACAD) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price acadia-pharm.com|ACAD - Price Target Chart
- market capitalization data:
Market Value ACADIA Pharmaceuticals|ACAD - Total Company Value
- book capitalization data:
Net Asset Value per Share ACADIA Pharmaceuticals|ACAD - Book Capitalization|Market Capitalization to Book Value Ratio acadia-pharm.com|ACAD - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio ACADIA Pharmaceuticals|ACAD - Long-Term Debt to Capital|Short-Term Debt to Capital ACADIA Corp|ACAD - Company Aggregate Debts|Debt to Book Value Ratio ACADIA Pharmaceuticals|ACAD - Company Long-Term Debts|Short-Term Debt Volume ACADIA Pharmaceuticals
Initial company analysis:ACAD (acadia-pharm.com)
Original product of ACADIA Pharmaceuticals Inc

Long-term debt measures the total volume of credit obligations with a maturity horizon exceeding one year, allowing for an assessment of financial stability and debt load risk. By analyzing the trajectory of the issuer's long-term liabilities, an investor can see the actual scale of borrowing, which for ACADIA Pharmaceuticals (ACAD) is offset by absolute pricing power in an inelastic market of unique drugs for the treatment of severe neurological disorders.

Competing companies

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|Xenon Corp (XENE) - Long-Term Debt|VKTX (Viking Therapeutics) - Company Long-Term Debts|Company Long-Term Debts supernus.com|Company Long-Term Debts CPRX (Catalyst Pharmaceuticals, Inc.)|Company Long-Term Liabilities Denali (DNLI)|Company Long-Term Debts HRMY (Harmony Pharma)|Company Long-Term Debts Biohaven Corp BHVN|Amylyx Pharmaceuticals (AMLX) - Company Long-Term Debts|TRVI - Company Long-Term Indebtedness|Praxis Precision Medicines, Inc. - Company Long-Term Debts|Anavex (AVXL) - Long-Term Debt Volume|CBLL (CeriBell Corp) - Company Long-Term Debts|Company Long-Term Debts prothena.com (PRTA)|Alector, Inc. (ALEC) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ANNX (annexonbio.com)|Omeros (OMER) - Company Long-Term Debt|Long-Term Liabilities Neurogene Inc NGNE|Company Long-Term Debts AC Immune Corp (ACIU)|VYGR - Company Long-Term Loans and Borrowings|NMRA: Company Long-Term Debts|SCLX (scilexholding.com) - Company Long-Term Debts|TVGN - Company Long-Term Debt|Company Long-Term Loans and Borrowings ACOG|Company Long-Term Debt CGTX (Cognition Therapeutics)|Company Long-Term Liabilities Inhibikase Pharma (IKT)|Company Long-Term Debts SAVA (Cassava Sciences, Inc.)|Company Long-Term Debts Assertio Holdings ASRT|COYA: Company Long-Term Debts|VTGN - Company Long-Term Liabilities|Company Long-Term Debts OVID|Long-Term Debt Acumen Pharmaceuticals, Inc|CRVO (CervoMed Inc.) - Company Long-Term Liabilities|Company Long-Term Debts Alterity Therapeutics Ltd (ATHE)|Company Long-Term Liabilities Clene Inc.|Amount of Long-Term Liabilities pepgen.com (PEPG)|Company Long-Term Debts JUNS|Long-Term Debt Volume Relmada Corp RLMD|ANVS: Company Long-Term Debts|GRCE - Company Long-Term Liabilities|AIFF: Company Long-Term Debts|KLTO (Klotho Neurosciences) - Company Long-Term Debts|Company Long-Term Debt NeuroSense Therapeutics Ltd|Company Long-Term Debt RVPH|MTVA (MetaVia Inc) - Company Long-Term Debt|Long-Term Debt Volume neuraxis.com (NRXS)|Company Long-Term Debts HSDT (Helius Medical Technologies)|Company Long-Term Debts Passage Bio Inc. PASG|NEUP: Company Long-Term Debts|NERV - Company Long-Term Liabilities|ATHA: Company Long-Term Debts|addextherapeutics.com (ADXN) - Company Long-Term Debts|Company Long-Term Debts Alzamend Neuro Inc. (ALZN)|Company Long-Term Indebtedness CYCN|Company Long-Term Debt Protagenic Therapeutics PTIX|Company Long-Term Indebtedness pasitheaclinics.com (KTTA)|CRGT: Company Long-Term Debts|ATXI - Long-Term Debt|BrainStorm Cell Therapeutics - Company Long-Term Liabilities|CARA: Company Long-Term Debts|Company Long-Term Debt Chromocell Therapeutics Corporation CHRO|ELYM (Eliem Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt ITCI (Intra-Cellular Therapies Inc.)|Long-Term Debt longboardpharma.com|Company Long-Term Debts MRNS|Company Long-Term Debts NKGen Biotech Inc (NKGN)|NeuroBo - Company Long-Term Debts|Company Long-Term Liabilities Sage Therapeutics Inc SAGE|Synaptogenix, Inc. - Company Long-Term Debts|TRVN - Company Long-Term Debts|Company Long-Term Debts vigilneuro.com|Anew Medical Inc. (WENA) - Company Long-Term Indebtedness|CERE: Company Long-Term Debts